What is COVID-19?
A mutated coronavirus strain called SARS-CoV-2 that first surfaced in 2019 is responsible for the infectious disease known as COVID-19. It is a highly contagious droplet and aerosol infection affecting millions worldwide. The viral particles are released into the air when an infected person speaks, sneezes, laughs, breathes, etc. This causes the infection to spread to those nearby. In March 2020, COVID-19 deemed a global pandemic due to the steadily rising infection rates.
What are covid 19 variants?
Like other RNA viruses, SARS-CoV-2 experiences spontaneous mutations. The virulence and infectiousness of the parent virus may change due to potential new Covid 19 virus variants. Furthermore, genomic alterations may increase the virus' resistance to immune responses brought on by a prior infection with SARS-CoV-2 or vaccination. As a result, the viral evolution may increase the likelihood of reinfection or reduce the effectiveness of vaccinations. Evidence supports the claim that some SARS-CoV-2 variants are less susceptible to particular monoclonal antibodies (mAbs) that are being considered for prevention and treatment.
Despite numerous initiatives to stop the spread of the disease and ongoing immunization campaigns, COVID-19 is still a widespread pandemic that is still going strong, with infection rates rising according to daily statistics. Let's examine the development of novel virus variants in more detail. The coronavirus has undergone continuous change since 2020 and has given rise to four new notable viral strains: Alpha, beta, delta, and omicron. Scientists have designated each evolved corona viral strain in Greek letters since the start of the pandemic in order to characterize better and distinguish them. Let's concentrate on these virus subtypes.
- Alpha variants: In November 2020, Alpha made its first appearance in the United Kingdom. Alpha was the first of the frequently reported early variations (B.1.1.7). Following its rapid global spread; infections peaked in December of that same year. In the United States, I was the most common variant by the end of 2020, and the CDC classified it as a variant of concern. Then, as the more aggressive Delta variant began to appear, the percentage of the Alpha variant began to decline drastically.
- Beta variants: This coronavirus variant, known as B.1.351, was identified in South Africa and had spread to other continents by the end of 2020. Experts have expressed concern due to its many mutations and propensity to elude antibodies. The beta virus was less prevalent in the US, though. The CDC claims that beta was more contagious than the original coronavirus by more than 50%.
- Delta variants: This virus variant was among the most well-known to be classified as a "Variant of Concern" by the WHO, was even more virulent. The most dangerous virus variant among all was discovered for the first time in India in late 2020.
- Omicron variants: In late November 2021, South Africa and Botswana reported the discovery of the first Omicron strain (BA.1), which quickly spread to nearby countries. In the US, the number of daily cases of Omicron infection had dramatically increased by December. Omicron subvariants BA.4 and BA.5 spread quickly and are very contagious. By the beginning of July 2022, one of those subvariants, BA.5, representing more than 50% of instances in the US, making it the dominant variant in this country. Worldwide research is being done on SARS Cov 2 variant samples to learn more about omicron and its subvariants, though.
Procure covid variant biospecimens from Word class biobanks.
Central BioHub, one of the most sophisticated biospecimen marketplaces in the world, collaborated with global biobanks to hasten ongoing research on COVID-19. We provide full access to high-quality covid 19 biospecimens for research. Studies on human biospecimens collected from the covid patients are known to aid scientists in understanding the biology, characteristics, and transmissibility of the recently evolved coronavirus strain. In view of this, Central BioHub offers a wide array of human serum, plasma, saliva, nasopharyngeal (NP), and oropharyngeal (OP) swabs or Covid 19 swab test samples collected from patients who are diagnosed with alpha, beta, delta, and omicron variant SARS-CoV-2 infections. The Covid 19 variant samples are thoroughly examined for SARS-CoV-2 using rapid antigen testing and CE-certified RT-qPCR, and they are stored at our partner's biobanks with strict quality controls. The samples are available for online purchase through Central BioHub's online marketplace. Hurry up! Check out our inventory and place your orders, quotes, and reservations online for covid 19 samples for research: https://centralbiohub.de/biospecimens/covid-19/variants.